Lowis SP - Search Results

1

Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitro.

Lowis SP, Newell DR, Pearson AD. Lowis SP, et al. Eur J Cancer. 1995;31A(4):622-6. doi: 10.1016/0959-8049(95)00026-f. Eur J Cancer. 1995. PMID: 7576982

2

Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG).

Davidson A, Gowing R, Lowis S, Newell D, Lewis I, Dicks-Mireaux C, Pinkerton CR. Davidson A, et al. Eur J Cancer. 1997 Oct;33(11):1816-22. doi: 10.1016/s0959-8049(97)00201-3. Eur J Cancer. 1997. PMID: 9470839 Clinical Trial.

3

Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro.

Lovat PE, Lowis SP, Pearson AD, Malcolm AJ, Redfern CP. Lovat PE, et al. Among authors: lowis sp. Neurosci Lett. 1994 Nov 21;182(1):29-32. doi: 10.1016/0304-3940(94)90197-x. Neurosci Lett. 1994. PMID: 7891881

4

Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.

Lowis SP, Pearson AD, Newell DR, Cole M. Lowis SP, et al. Cancer Res. 1993 Oct 15;53(20):4881-9. Cancer Res. 1993. PMID: 8402676

5

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.

English MW, Lowis SP, Peng B, Boddy A, Newell DR, Price L, Pearson AD. English MW, et al. Among authors: lowis sp. Br J Cancer. 1996 Mar;73(6):776-80. doi: 10.1038/bjc.1996.135. Br J Cancer. 1996. PMID: 8611379 Free PMC article.

6

Etoposide for the treatment of paediatric tumours: what is the best way to give it?

Lowis SP, Newell DR. Lowis SP, et al. Eur J Cancer. 1996 Dec;32A(13):2291-7. doi: 10.1016/s0959-8049(96)00301-2. Eur J Cancer. 1996. PMID: 9038612 Review.

7

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.

Lowis SP, Price L, Pearson AD, Newell DR, Cole M. Lowis SP, et al. Br J Cancer. 1998 Jun;77(12):2318-23. doi: 10.1038/bjc.1998.385. Br J Cancer. 1998. PMID: 9649152 Free PMC article. Clinical Trial.

8

Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin.

Lowis SP, Pearson AD, Reid MM, Craft AW. Lowis SP, et al. Cancer Chemother Pharmacol. 1993;31(5):415-8. doi: 10.1007/BF00686158. Cancer Chemother Pharmacol. 1993. PMID: 8431977 Clinical Trial.

9

Biliary excretion of etoposide in children with cancer.

Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S. Veal GJ, et al. Cancer Chemother Pharmacol. 2006 Sep;58(3):415-7. doi: 10.1007/s00280-005-0180-7. Epub 2006 Jan 18. Cancer Chemother Pharmacol. 2006. PMID: 16418874

10

Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).

Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Woessmann W, Beck O, Flotho C, Grigull L, Driever PH, Schlegel PG, Khurana C, Hering K, Kolb R, Leipold A, Abbink F, Gil-Da-Costa MJ, Benesch M, Kerl K, Lowis S, Marques CH, Graf N, Nysom K, Vokuhl C, Melchior P, Kröncke T, Schneppenheim R, Kordes U, Gerss J, Siebert R, Furtwängler R, Frühwald MC. Nemes K, et al. Eur J Cancer. 2021 Jan;142:112-122. doi: 10.1016/j.ejca.2020.10.004. Epub 2020 Nov 27. Eur J Cancer. 2021. PMID: 33249395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters